All Episodes

June 2, 2025 5 mins
# Breaking News: Novo Nordisk Slashes Wegovy Prices as FDA Ends Compounding

In this timely episode, we explore Novo Nordisk's strategic move to temporarily reduce Wegovy pricing to $199 for the first month and $499 thereafter for new self-paying patients. This price cut coincides with the FDA ending its grace period for compounded GLP-1 medications, potentially reshaping access to weight loss treatments. We discuss the implications for patients seeking affordable options, with remarkable success stories highlighting Wegovy's effectiveness—87% of users losing over 10% of their body weight. Plus, get exclusive insights on Novo Nordisk's upcoming oral Wegovy formulation that could revolutionize obesity treatment. Whether you're considering weight management options or following pharmaceutical industry trends, this episode delivers essential information on the changing landscape of GLP-1 medications and what it means for consumers and healthcare providers alike.
Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
The Joe Rogan Experience

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.